By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

YEAR FOUNDED:

1858

LEADERSHIP:

Founder: Edward Robinson Squibb

CEO: Giovanni Caforio, MD

CFO: Charles Bancroft

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Bristol-Myers Squibb job opportunities.

PRODUCTS:

Please click here to see all products.

For more information, visit
www.bms.com and follow us on www.twitter.com/BMSNEWS.

FOLLOW BRISTOL-MYERS SQUIBB:





Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 





Company News
Zoning Changes Kills Sale of Bristol-Myers Squibb (BMY)'s Connecticut Campus 2/21/2017 5:59:30 AM
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017 5:47:34 AM
How Bristol-Myers Squibb (BMY) And Pfizer (PFE) Are Stomping On Their Blood Thinner Rivals 2/17/2017 6:45:25 AM
Bristol-Myers Squibb (BMY) May Be on the Market, But Pfizer (PFE) Probably Won't Bite 2/16/2017 6:18:03 AM
Bristol-Myers Squibb (BMY) Could Finally Go on the Market; Rumored Suitors Include Gilead (GILD), Pfizer (PFE), Novartis AG (NVS) and Roche (RHHBY) 2/14/2017 10:38:25 AM
Another Letdown for Bristol-Myers Squibb (BMY) as Partner Innate Pharma (IPH.PA )'s Leukemia Candidate Flunks Phase II Test 2/6/2017 5:21:01 AM
Bristol-Myers Squibb (BMY) Receives FDA Approval For Opdivo (Nivolumab) In Previously Treated Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer 2/3/2017 8:13:06 AM
3 Biotechs Breathing Down Bristol-Myers Squibb (BMY)'s Neck 2/3/2017 5:47:54 AM
Bristol-Myers Squibb (BMY) Release: Cancer Survivors Need More Efficient Integrated Long-Term Care And Stronger Policies Across Healthcare, Advocacy And The Workplace, New Research Concludes 2/2/2017 11:25:44 AM
Bristol-Myers Squibb (BMY) Announces European Patent Office Decision On Sprycel 2/1/2017 11:00:59 AM
12345678910...
//-->